CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ROMEO project focuses on improving cancer nanomedicine by developing a new therapeutic vector that can evade liver uptake and effectively target tumor cells. By combining extracellular vesicles with optimized nanoparticles, it aims to enhance drug delivery to tumors, addressing the limitations of current nanomedici…
Today cancer remains a huge health concern, with around 20 million new cases and 10 million deaths per year worldwide.
However, according to expectations, Nanomedicine should have ended cancer long time ago.
The first nanomedicine (DoxilTM) a liposomal formulation based on the Enhanced Permeation and Retention (EPR) effect, dates from 1995.
In the ensuing three decades, hundreds of anticancer nanoparticles with exciting properties were developed, but only a handful have reached the clinic, with…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
